Are you a journalist? Please sign up here for our press releases
A non-surgical treatment for low-risk prostate cancer in which doctors inject a light-sensitive drug derived from deep-sea bacteria into a patient's bloodstream was shown in a trial to kill cancer cells without destroying healthy tissue.
A non-surgical treatment for low-risk prostate cancer in which doctors inject a light-sensitive drug derived from deep-sea bacteria into a patient's bloodstream was shown in a trial to kill cancer cells without destroying healthy tissue.